Vanguard Group’s Repros Therapeutics Inc. RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $486K | Sell |
|
|||||
|
2017
Q3 | $256K | Buy |
|
|||||
|
2017
Q2 | $366K | Sell |
|
|||||
|
2017
Q1 | $1.07M | Buy |
|
|||||
|
2016
Q4 | $1.17M | Sell |
|
|||||
|
2016
Q3 | $2M | Sell |
|
|||||
|
2016
Q2 | $1.62M | Buy |
|
|||||
|
2016
Q1 | $805K | Buy |
|
|||||
|
2015
Q4 | $1M | Buy |
|
|||||
|
2015
Q3 | $5.67M | Buy |
|
|||||
|
2015
Q2 | $5.03M | Sell |
|
|||||
|
2015
Q1 | $6.07M | Buy |
|
|||||
|
2014
Q4 | $6.48M | Sell |
|
|||||
|
2014
Q3 | $6.51M | Buy |
|
|||||
|
2014
Q2 | $11.1M | Buy |
|
|||||
|
2014
Q1 | $10.8M | Buy |
|
|||||
|
2013
Q4 | $10.4M | Buy |
|
|||||
|
2013
Q3 | $14.7M | Buy |
|
|||||
|
2013
Q2 | $9.61M | Buy |
|